Home › Funds › C WorldWide Group Holding A/S › BMRN
C WorldWide Group Holding A/S position in BMRN
BIOMARIN PHARMACEUTICAL INC · Health Care
C WorldWide Group Holding A/S reported holding 267,851 shares of BMRN (BIOMARIN PHARMACEUTICAL INC) in its Q3 2026 13F filing — a position valued at US$16.1M, representing 0.41% of its reported portfolio and ranking #39 among its reported holdings. C WorldWide Group Holding A/S has disclosed BMRN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How C WorldWide Group Holding A/S's BMRN position evolved
C WorldWide Group Holding A/S first disclosed a stake in BMRN in Q3 2023 at 253,851 shares (US$22.5M). The position peaked in Q4 2023 at 303,851 shares, worth US$29.3M. Across 13 filings, C WorldWide Group Holding A/S increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 9 time(s). The most recent filing (Q3 2026) shows 267,851 shares valued at US$16.1M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 253.85K | $22.46M | New |
| Q4 2023 | 303.85K | $29.30M | Add |
| Q1 2024 | 303.85K | $26.54M | Hold |
| Q2 2024 | 303.85K | $25.02M | Hold |
| Q3 2024 | 303.85K | $21.36M | Hold |
| Q4 2024 | 303.85K | $19.97M | Hold |
| Q1 2025 | 237.85K | $16.81M | Reduce |
| Q2 2025 | 237.85K | $13.07M | Hold |
| Q3 2025 | 237.85K | $12.88M | Hold |
| Q4 2025 | 267.85K | $15.92M | Add |
| Q1 2026 | 267.85K | $15.13M | Hold |
| Q2 2026 | 267.85K | $15.33M | Hold |
| Q3 2026 | 267.85K | $16.07M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About BMRN and 13F data
BMRN (BIOMARIN PHARMACEUTICAL INC) is a Health Care company. 26 other funds we track also report a position in BMRN — the largest reported positions include PRIMECAP MANAGEMENT CO/CA/ (US$899.3M), Viking Global Investors (US$435.8M), VIKING GLOBAL INVESTORS LP (US$435.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding BMRN
- PRIMECAP MANAGEMENT CO/CA/ 14.99M sh · $899.34M · Q3 2026
- Viking Global Investors 7.62M sh · $435.82M · Q2 2026
- VIKING GLOBAL INVESTORS LP 7.62M sh · $435.82M · Q2 2026
- Vestal Point Capital, LP 6.03M sh · $344.75M · Q2 2026
- Deep Track Capital, LP 3.31M sh · $189.25M · Q2 2026
- TENOR CAPITAL MANAGEMENT Co., L.P. 111.50M sh · $108.89M · Q2 2026
More on C WorldWide Group Holding A/S
FAQ
How long has C WorldWide Group Holding A/S held BMRN?
C WorldWide Group Holding A/S has disclosed BMRN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is C WorldWide Group Holding A/S's current position in BMRN?
As of Q3 2026, C WorldWide Group Holding A/S holds 267.85K shares of BMRN (BIOMARIN PHARMACEUTICAL INC), valued at $16.07M, representing 0.41% of its reported portfolio and ranking #39.
Has C WorldWide Group Holding A/S been buying or selling BMRN?
In the latest 13F filing (Q3 2026), C WorldWide Group Holding A/S held unchanged its position in BMRN. The position peaked in Q4 2023 at 303.85K shares.
Which other funds hold BMRN?
Other major institutional holders of BMRN include PRIMECAP MANAGEMENT CO/CA/, Viking Global Investors, VIKING GLOBAL INVESTORS LP, among 26 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.